Spyre Therapeutics · 2 hours ago
Senior Manager, Data Management
Spyre Therapeutics is a clinical-stage biotechnology company focused on pioneering long-acting antibodies for inflammatory bowel disease and rheumatic diseases. They are seeking a Senior Manager, Data Management to lead clinical data management activities, ensuring data quality and compliance throughout the study lifecycle.
BiotechnologyTherapeutics
Responsibilities
Perform data management study activities and manage timelines during study start-up, study conduct, database lock, and documentation archival
Conduct oversight of and provide guidance to data management CROs to ensure that data management documents and tasks are completed and delivered in accordance with timelines and data quality standards
Oversee and drive development of study related data management deliverables (e.g., eCRF, DTA, etc.)
Participate in the implementation and UAT of clinical systems (e.g., EDC, IRT, eCOA)
Coordinate cross functional data review and provide proactive review of data trends and issue resolution
Other duties as assigned
Qualification
Required
Bachelor's degree is required
10+ years of data management experience in the pharmaceutical, biotech, or CRO industry, with 5-8 years as a Lead Data Manager
Hands-on knowledge and experience in data management activities, such as CRF and EDC design, review, and validation of data from various vendors
Knowledge of real-time data flow across clinical systems
Strong knowledge of EDC systems (Medidata Rave, Veeva, or equivalent)
Knowledge of GCP, ICH, and regulatory requirements
Successful track record of working independently in a matrixed organization or in a start-up environment and providing effective solutions to emerging problems
Excellent interpersonal communication skills, along with organizational skills
Benefits
Market competitive compensation and benefits package, including base salary, performance bonus, equity grant opportunities, health, welfare & retirement benefits.
Unlimited PTO
Two, one-week company-wide shutdowns each
Commitment to provide professional development opportunities.
Remote working environment with frequent in-person meetings to address complex problems and build relationships.
Company
Spyre Therapeutics
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.
Funding
Current Stage
Public CompanyTotal Funding
$835M2025-10-13Post Ipo Equity· $275M
2024-11-18Post Ipo Equity· $200M
2024-03-18Post Ipo Equity· $180M
Recent News
thefly.com
2026-01-03
2025-12-01
Company data provided by crunchbase